Literature DB >> 25011064

European survey on laboratory preparedness, response and diagnostic capacity for Crimean-Congo haemorrhagic fever, 2012.

M D Fernandez-Garcia1, A Negredo, A Papa, O Donoso-Mantke, M Niedrig, H Zeller, A Tenorio, L Franco.   

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is an infectious viral disease that has (re-)emerged in the last decade in south-eastern Europe, and there is a risk for further geographical expansion to western Europe. Here we report the results of a survey covering 28 countries, conducted in 2012 among the member laboratories of the European Network for Diagnostics of 'Imported' Viral Diseases (ENIVD) to assess laboratory preparedness and response capacities for CCHF. The answers of 31 laboratories of the European region regarding CCHF case definition, training necessity, biosafety, quality assurance and diagnostic tests are presented. In addition, we identified the lack of a Regional Reference Expert Laboratory in or near endemic areas. Moreover, a comprehensive review of the biosafety level suitable to the reality of endemic areas is needed. These issues are challenges that should be addressed by European public health authorities. However, all respondent laboratories have suitable diagnostic capacities for the current situation.

Entities:  

Mesh:

Year:  2014        PMID: 25011064     DOI: 10.2807/1560-7917.es2014.19.26.20844

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  4 in total

Review 1.  Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.

Authors:  Vanessa N Raabe
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

Review 2.  Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks.

Authors:  Barbara Bartolini; Cesare Em Gruber; Marion Koopmans; Tatjana Avšič; Sylvia Bino; Iva Christova; Roland Grunow; Roger Hewson; Gulay Korukluoglu; Cinthia Menel Lemos; Ali Mirazimi; Anna Papa; Maria Paz Sanchez-Seco; Aisha V Sauer; Hervè Zeller; Carla Nisii; Maria Rosaria Capobianchi; Giuseppe Ippolito; Chantal B Reusken; Antonino Di Caro
Journal:  Euro Surveill       Date:  2019-01

3.  Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.

Authors:  Petra Emmerich; Ronald von Possel; Christina Deschermeier; Salih Ahmeti; Lindita Berisha; Bahrije Halili; Xhevat Jakupi; Kurtesh Sherifi; Claudia Messing; Viola Borchardt-Lohölter
Journal:  PLoS Negl Trop Dis       Date:  2021-03-15

4.  Development of multivalent vaccine targeting M segment of Crimean Congo Hemorrhagic Fever Virus (CCHFV) using immunoinformatic approaches.

Authors:  Maaza Sana; Aneela Javed; Syed Babar Jamal; Muhammad Junaid; Muhammad Faheem
Journal:  Saudi J Biol Sci       Date:  2021-12-10       Impact factor: 4.052

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.